These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12511770)

  • 1. CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo.
    Menniti FS; Buchan AM; Chenard BL; Critchett DJ; Ganong AH; Guanowsky V; Seymour PA; Welch WM
    Stroke; 2003 Jan; 34(1):171-6. PubMed ID: 12511770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models.
    Gigler G; Móricz K; Agoston M; Simó A; Albert M; Benedek A; Kapus G; Kertész S; Vegh M; Barkóczy J; Markó B; Szabó G; Matucz E; Gacsályi I; Lévay G; Hársing LG; Szénási G
    Br J Pharmacol; 2007 Sep; 152(1):151-60. PubMed ID: 17603549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of YM90K, an AMPA-receptor antagonist, against delayed neuronal death induced by transient global cerebral ischemia in gerbils and rats.
    Kawasaki-Yatsugi S; Yatsugi S; Koshiya K; Shimizu-Sasamata M
    Jpn J Pharmacol; 1997 Jul; 74(3):253-60. PubMed ID: 9268085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the AMPA antagonist action of new 2,3-benzodiazepines in vitro and their neuroprotective effects in vivo.
    Kapus G; Kertész S; Gigler G; Simó A; Vegh M; Barkóczy J; Hársing LG; Szabó G; Lévay G
    Pharm Res; 2004 Feb; 21(2):317-23. PubMed ID: 15032314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia.
    Gill R
    Cerebrovasc Brain Metab Rev; 1994; 6(3):225-56. PubMed ID: 7529037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
    Hu P; Diemer NH; Bruhn T; Johansen FF
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties.
    Weiser T; Brenner M; Palluk R; Bechtel WD; Ceci A; Brambilla A; Ensinger HA; Sagrada A; Wienrich M
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1343-9. PubMed ID: 10336525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia.
    O'Neill MJ; Bond A; Ornstein PL; Ward MA; Hicks CA; Hoo K; Bleakman D; Lodge D
    Neuropharmacology; 1998; 37(10-11):1211-22. PubMed ID: 9849659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
    Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.
    Takahashi M; Kohara A; Shishikura J; Kawasaki-Yatsugi S; Ni JW; Yatsugi S; Sakamoto S; Okada M; Shimizu-Sasamata M; Yamaguchi T
    CNS Drug Rev; 2002; 8(4):337-52. PubMed ID: 12481190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
    Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
    J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of CP-465,022, a selective, noncompetitive AMPA receptor antagonist.
    Lazzaro JT; Paternain AV; Lerma J; Chenard BL; Ewing FE; Huang J; Welch WM; Ganong AH; Menniti FS
    Neuropharmacology; 2002 Feb; 42(2):143-53. PubMed ID: 11804610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia.
    Arias RL; Tasse JR; Bowlby MR
    Brain Res; 1999 Jan; 816(2):299-308. PubMed ID: 9878799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 9-Carboxymethyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one-2-carbocylic acid (RPR117824): selective anticonvulsive and neuroprotective AMPA antagonist.
    Mignani S; Bohme GA; Birraux G; Boireau A; Jimonet P; Damour D; Genevois-Borella A; Debono MW; Pratt J; Vuilhorgne M; Wahl F; Stutzmann JM
    Bioorg Med Chem; 2002 May; 10(5):1627-37. PubMed ID: 11886824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia.
    Erdo F; Berzsenyi P; Andrási F
    Brain Res Bull; 2005 Jul; 66(1):43-9. PubMed ID: 15925143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complestatin is a noncompetitive peptide antagonist of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors: secure blockade of ischemic neuronal death.
    Seo SY; Yun BS; Ryoo IJ; Choi JS; Joo CK; Chang SY; Chung JM; Oh S; Gwag BJ; Yoo ID
    J Pharmacol Exp Ther; 2001 Oct; 299(1):377-84. PubMed ID: 11561102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuroprotective effect of the novel AMPA receptor antagonist PD152247 (PNQX) in temporary focal ischemia in the rat.
    Schielke GP; Kupina NC; Boxer PA; Bigge CF; Welty DF; Iadecola C
    Stroke; 1999 Jul; 30(7):1472-7. PubMed ID: 10390325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S; Yatsugi S; Takahashi M; Toya T; Ichiki C; Shimizu-Sasamata M; Yamaguchi T; Minematsu K
    Brain Res; 1998 May; 793(1-2):39-46. PubMed ID: 9630503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model.
    Kawasaki-Yatsugi S; Ichiki C; Yatsugi S; Takahashi M; Shimizu-Sasamata M; Yamaguchi T; Minematsu K
    Neuropharmacology; 2000 Jan; 39(2):211-7. PubMed ID: 10670416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.